| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4273717 | Progrès en Urologie - FMC | 2015 | 5 Pages |
Abstract
These promising tests combine the advantage of being minimally invasive and relatively simple. However, the heterogeneity of prostate cancer associated with individual variations needed to validate these tools prospectively on large cohorts of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
C.M. Champy, A. de la Taille,